Your browser is no longer supported. Please, upgrade your browser.
Quotient Limited
Index- P/E- EPS (ttm)-1.17 Insider Own1.20% Shs Outstand101.01M Perf Week-2.07%
Market Cap444.62M Forward P/E- EPS next Y-0.88 Insider Trans-9.14% Shs Float75.66M Perf Month16.39%
Income-108.50M PEG- EPS next Q-0.27 Inst Own91.00% Short Float7.45% Perf Quarter3.90%
Sales43.40M P/S10.24 EPS this Y17.50% Inst Trans-0.99% Short Ratio10.42 Perf Half Y-36.51%
Book/sh-0.29 P/B- EPS next Y17.80% ROA-46.30% Target Price- Perf Year-45.45%
Cash/sh1.07 P/C3.98 EPS next 5Y- ROE- 52W Range3.41 - 8.77 Perf YTD-18.23%
Dividend- P/FCF- EPS past 5Y7.30% ROI-54.20% 52W High-52.48% Beta2.26
Dividend %- Quick Ratio2.10 Sales past 5Y18.60% Gross Margin53.70% 52W Low22.14% ATR0.24
Employees435 Current Ratio2.40 Sales Q/Q10.30% Oper. Margin- RSI (14)50.02 Volatility4.71% 6.21%
OptionableYes Debt/Eq- EPS Q/Q-23.10% Profit Margin- Rel Volume0.36 Prev Close4.26
ShortableYes LT Debt/Eq- EarningsJun 01 BMO Payout- Avg Volume540.73K Price4.16
Recom1.70 SMA20-1.92% SMA504.42% SMA200-16.57% Volume110,706 Change-2.23%
Jun-03-21Initiated Goldman Neutral $5
Aug-31-17Resumed BTIG Research Buy $12
Nov-04-15Reiterated UBS Buy $25 → $26
Aug-11-15Initiated Jefferies Buy $30
Feb-04-15Reiterated UBS Buy $17 → $25
Jun-10-21 09:32AM  
Jun-01-21 06:30AM  
May-31-21 08:00AM  
May-25-21 08:30AM  
May-24-21 08:00AM  
Apr-12-21 09:00AM  
Apr-05-21 04:05PM  
Mar-02-21 08:00AM  
Mar-01-21 10:54AM  
Feb-24-21 04:05PM  
Feb-23-21 06:20AM  
Feb-16-21 01:27PM  
Feb-12-21 09:00AM  
Feb-01-21 07:30AM  
Jan-25-21 12:30PM  
Jan-19-21 08:00AM  
Jan-12-21 09:10AM  
Jan-08-21 05:42AM  
Dec-22-20 04:05PM  
Dec-10-20 08:30AM  
Nov-30-20 04:05PM  
Nov-09-20 04:05PM  
Nov-04-20 10:05AM  
Nov-02-20 08:27AM  
Oct-29-20 12:57PM  
Oct-26-20 12:31PM  
Oct-19-20 08:48AM  
Sep-28-20 07:00AM  
Sep-19-20 07:00AM  
Sep-16-20 11:07AM  
Sep-15-20 04:05PM  
Sep-14-20 03:37PM  
Sep-10-20 08:42PM  
Sep-09-20 04:05PM  
Sep-08-20 06:15AM  
Aug-27-20 08:30AM  
Aug-04-20 09:15AM  
Aug-03-20 07:48AM  
Jul-28-20 10:49AM  
Jul-23-20 08:30AM  
Jul-20-20 10:09PM  
Jul-17-20 08:00AM  
Jul-01-20 08:00AM  
Jun-22-20 10:35AM  
Jun-11-20 10:21AM  
Jun-09-20 07:17AM  
May-26-20 04:30PM  
May-19-20 12:30PM  
May-11-20 02:00AM  
May-01-20 09:00AM  
Apr-27-20 04:05PM  
Apr-21-20 04:05PM  
Apr-06-20 08:00AM  
Mar-15-20 09:47AM  
Mar-13-20 04:30PM  
Feb-24-20 04:05PM  
Feb-14-20 08:04AM  
Feb-05-20 12:49AM  
Feb-04-20 10:08AM  
Feb-03-20 06:33AM  
Jan-30-20 07:30AM  
Jan-23-20 12:31PM  
Jan-21-20 08:00AM  
Jan-13-20 10:42AM  
Jan-10-20 04:05PM  
Jan-08-20 08:00AM  
Jan-07-20 04:05PM  
Dec-09-19 09:52AM  
Dec-05-19 04:05PM  
Nov-18-19 09:00AM  
Nov-12-19 04:05PM  
Nov-09-19 10:25PM  
Nov-06-19 10:00PM  
Nov-04-19 07:30AM  
Oct-31-19 08:00AM  
Oct-30-19 11:18AM  
Oct-28-19 10:32AM  
Oct-21-19 06:00AM  
Oct-17-19 04:51PM  
Oct-14-19 03:46PM  
Aug-14-19 01:31PM  
Aug-12-19 04:33AM  
Aug-05-19 12:23PM  
Jul-29-19 10:34AM  
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stackawitz JeremyChief Commercial OfficerFeb 04Sale5.1430,000154,197112,926Feb 08 04:05 PM
Farrell EdwardChief Operating Officer (+)Feb 03Sale5.0796,000487,05629,757Feb 05 04:20 PM
PERCEPTIVE ADVISORS LLC10% OwnerSep 15Buy4.252,911,76412,374,99716,200,818Sep 16 08:30 AM